Atlas Trials

Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults

Clinical trial NCT03039790 · COMPLETED

Trial details

NCT number
NCT03039790
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Healthy VolunteersNorovirus
Start date
2017-02-21
Primary completion
2021-07-22
Enrollment
528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.